Rousselot and xolo Strengthen Collaboration in 3D Bioprinting Research with Co-Branding Agreement
Irving, Texas, USA, 26th September 2024 / Rousselot, Darling Ingredients’ premier collagen and gelatin brand, and xolo, a German company specializing in 3D printing for research and medical applications, today announced a co-branding agreement. This collaboration integrates Rousselot’s X-Pure® GelMA solution into xolo’s ready-to-use bioinks for volumetric 3D printers.
xolo, known for its high-performance bioprinters, uses its proprietary Xolography technology to print complex cellular structures quickly and accurately. Rousselot Biomedical, an expert in biomedical gelatins, offers the X-Pure range, recognized for its exceptional purity and consistency. X-Pure GelMA (gelatin methacrylate), when used in bioinks, is designed to deliver exceptional stable and reproducible printing results while supporting optimal cell growth.
“We are dedicated to accelerating medical research by bridging the gap between research and clinical application,” said Tanja Vervust, Director of Rousselot Biomedical. “Our X-Pure range, available in GMP and research-equivalent grades, is ideal for translational research. We are thrilled to collaborate with xolo, a start-up at the forefront of biomedical innovation.”
Stephan Kuehr, Chief Commercial Officer of xolo, added: “Our customers expressed a need for GelMA bio-ink with consistent purity, ready to be used with our volumetric printers, allowing our clients to fully focus on their research without concerns about quality issues. We’re excited to collaborate with Rousselot, which shares our vision for enabling faster, more reliable bioprinting solutions. Together, we can meet these needs by providing high-quality, ready-to-use bioinks that perfectly complement our advanced printing technology, helping researchers push the boundaries of biomedical innovation.”
This agreement marks an important step in the field of bioprinting, creating new opportunities for researchers by providing access to materials of outstanding quality and reliability.
ENDS
For further information, please contact:
Rousselot
Caroline Brochard-Garnier
Director Communications & PR, Rousselot
E: Caroline.brochard-garnier@rousselot.com
xolo
Stephan Kuehr
Chief Commercial Officer
E: sk@xolo3d.com
Sciad Communications
Maria Patey
Director
E: maria@sciad.com
Notes for Editors
Rousselot
Rousselot, the brand of Darling’s Ingredients Health, is a global leader in gelatin- and collagen-based solutions for the food, health & nutrition, biomedical and pharmaceutical industries. Working in partnership with their global customer base, they deliver advanced ingredient solutions that enable innovation, excite today’s consumers and contribute to public health.
About Rousselot
Rousselot, the health brand of Darling Ingredients, is a global leader in gelatin- and collagen-based solutions for the food, health & nutrition, biomedical and pharmaceutical industries. Working in partnership with our global customer base, we deliver advanced ingredient solutions that enable innovation, excite today’s consumers, and contribute to public health. Through our state-of-the-art operations, extensive technical expertise and sustained scientific research, we help our customers achieve their goals and create world-class products, and we “Reach further together.”
About xolo
xolo GmbH is a leader in volumetric 3D printing, using its Xolography technology to advance bioprinting and medical research. Based in Berlin, xolo specializes in printing bio-compatible materials and complex medical structures fast, with high precision and without layers. Their cutting-edge solutions enable researchers in fields like tissue engineering, regenerative medicine, and biomedical applications to push the limits of innovation, paving the way for next-generation medical technologies.
Got an innovation you need bringing to life?
We’d love to hear from you! Head to our contact page to start a conversation.
